Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001178913-19-001142
Filing Date
2019-04-15
Accepted
2019-04-15 16:06:21
Documents
45
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K zk1922876.htm 10-K 716560
2 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 9463
3 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 4721
10 image00001.jpg GRAPHIC 39235
  Complete submission text file 0001178913-19-001142.txt   2505801

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT atms-20181231.xml EX-101.INS 373676
5 XBRL TAXONOMY EXTENSION SCHEMA atms-20181231.xsd EX-101.SCH 29246
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20181231_cal.xml EX-101.CAL 24295
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20181231_def.xml EX-101.DEF 84906
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20181231_lab.xml EX-101.LAB 188447
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20181231_pre.xml EX-101.PRE 140383
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

EIN.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24431 | Film No.: 19748660
SIC: 2890 Miscellaneous Chemical Products